Executive Summary

Roughly 20 million people in developed markets with chronic GI issues (IBS/IBD and those on elimination diets) spend months trying to identify food and lifestyle triggers with inconsistent, high-burden methods and clinicians rarely receive the structured longitudinal data they need to help. That friction causes wasted visits, ongoing symptoms, and willingness to pay for better, actionable tracking. You could build a low-burden HealthTech app that combines simple daily symptom and meal logging, passive context from integrations (sleep, activity, stress), and NLP+pattern-detection to generate prioritized, testable trigger hypotheses and clinician-shareable visit summaries. Add guided elimination protocols, A/B style n-of-1 testing, and exportable reports to drive real clinical value. This is timely: the total addressable market is roughly $6.0B (20M users × $300 ACV), market score 88/100 and revenue potential 82/100, and trends toward self-management, reimbursable digital therapeutics, and clinician demand for structured data support rapid adoption. Payer and clinic partnerships could accelerate growth if you can show outcomes and cost-offsets. You can differentiate by focusing on clinician-grade reports, validated trigger-detection algorithms (leveraging modern NLP instead of manual tagging), and a clear path to reimbursement. Be upfront that the biggest challenges are confirming clinical validity, maintaining long-term user adherence, and meeting privacy/regulatory requirements—plan early pilot studies and provider integrations to de-risk.

Market Opportunity

Track gut symptoms and diet to personalize relief for IBS/IBD targets a $6.0B = 20M users willing to pay × $300 ACV average (global chronic GI sufferers and elimination-diet users in developed markets) total addressable market with medium saturation and a year-over-year growth rate of 20% YoY (digital health and digital therapeutics growth estimates; sources include Grand View Research and Startup funding trends).

Key trends driving demand: Trend — Patients increasingly self-manage chronic conditions and seek apps that produce clinician-shareable reports, creating demand for structured longitudinal tracking.; Trend — Digital therapeutics and reimbursable remote care services are gaining reimbursement pathways, which creates a route to clinician and payer adoption.; Trend — Advances in NLP and pattern-detection make personalized hypothesis generation (e.g., likely food triggers) feasible without large on-prem data science teams.; Trend — Rising consumer interest in gut health, microbiome testing and personalized nutrition increases willingness to try and pay for focused gut-health apps..

Key competitors include Cara Care, mySymptoms (Food Diary), Monash FODMAP Diet App.

Sign in to access

Track gut symptoms and diet to personalize relief for IBS/IBD

Executive Summary

Market Validation

Market Opportunity

More in HealthTech

Replace manual pharmacy ops with AI-driven billing, inventory & CRM

Helping people manage stress & anxiety with a personalized AI companion

Cumbersome food logging -> passive AI meal capture with portion inference

HIPAA BAA blockers — AI contract review + pre-approved vendor marketplace

Reduce missed clinic appointments by automating patient outreach via WhatsApp

Too many leads not converting — automate patient conversion flow